Damora Therapeutics (DMRA) Treasury Shares (2024 - 2026)
Damora Therapeutics posted quarterly Treasury Shares of $957513.0 for Q1 2026, up 9061.05% year-on-year from $10452.0 in Q1 2025, and up 12175.81% on a QoQ basis from $7800.0 in Q4 2025.
Damora Therapeutics (DMRA) has 3 years of Treasury Shares data on file, last reported at $957513.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 9061.05% year-over-year to $957513.0; the trailing twelve-month figure through Mar 2026 stood at $957513.0 (up 9061.05% YoY), and the FY2025 full-year result was $7800.0, down 50.0% from the prior year.
- Treasury Shares for Q1 2026 stood at $957513.0, up from $7800.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $957513.0 in Q1 2026 and bottomed at $7800.0 in Q3 2025.
- The 3-year median for Treasury Shares is $15600.0 (2024), against an average of $283468.6.
- The widest annual swing landed in 2025, when Treasury Shares tumbled 98.73%; it then jumped 9061.05% in 2026.
- A 3-year view of Treasury Shares shows it stood at $15600.0 in 2024, then sank by 50.0% to $7800.0 in 2025, then jumped by 12175.81% to $957513.0 in 2026.
- The last three Treasury Shares figures came in at $957513.0 (Q1 2026), $7800.0 (Q4 2025), and $7800.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - | 957,513.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 957,513.00 |
| Mar 31, 2026 | 957,513.00 |
| Dec 31, 2025 | 7,800.00 |
| Dec 31, 2025 | 7,800.00 |
| Sep 30, 2025 | 7,800.00 |
| Sep 30, 2025 | 7,800.00 |
| Jun 30, 2025 | 10,452.00 |
| Jun 30, 2025 | 10,452.00 |
| Mar 31, 2025 | 10,452.00 |
| Mar 31, 2025 | 10,452.00 |
| Dec 31, 2024 | 15,600.00 |
| Dec 31, 2024 | 15,600.00 |
| Sep 30, 2024 | 16,600.00 |
| Sep 30, 2024 | 16,600.00 |
| Jun 30, 2024 | 705,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Mar 31, 2024 | 820,000.00 |
| Mar 31, 2024 | 820,000.00 |